Business, Free News Articles, Regional Events, Surgery and Neurotechnology

Neuroprosthetics Pioneer to Keynote at the 2018 Neurotech Leaders Forum in San Francisco

SAN FRANCISCO, Calif. -- Neurotech Reports today announced that the keynote speaker at the 18th annual Neurotech Leaders Forum will be Hunter Peckham, a pioneer in the field of neuroprosthetics, technology that restores movement for people living with paralysis.

Peckham is a Distinguished University Professor and Donnell Institute Professor of Biomedical Engineering at Case Western Reserve University. He is also associate director of technology transfer at the Cleveland FES Center and the founder of the Institute for Functional Restoration. The event will take place October 15-16 in San Francisco, Calif.

Frank Fischer, CEO of NeuroPace Inc., has also been added to the agenda as a keynote speaker. Other additions include Eddie Chang, co-director of the Center for Neural Engineering at UC Berkeley and UC San Francisco, Philip Starr, professor of neurosurgery at UCSF, Michael Ackermann, CEO of Presidio Medical, Bashar Badran from the U.S. Army Research Laboratories, Cristin Welle, a former FDA employee and now assistant professor at University of Colorado, Nick Langhals, Neural Engineering Program Manager at the National Institutes of Health, and John Donoghue, director of the Wyss Center for Neuro and Bioengineering.

Executives from several early-stage and emerging neurotech startups will also make presentations during the event. These include Manfred Franke, founder and CEO of Neuronoff Inc., Bill Edelman, chairman of Highland Instruments, Erik Nilsen, CEO of Bio-Signal Technologies, LLC, and Howard Leonhardt, CEO of CerebraCell.

The conference returns to the Embassy Suites San Francisco Airport-Waterfront in Burlingame, Calif. Platinum Sponsor at this year's conference will be Cirtec Medical. Micro Systems Technologies is the Gold Sponsor. Other sponsors include IMEC, Cactus Semiconductor, Hereaus, Senso Medical, RBrooks Group, Maynard Cooper, Cleveland FES Center, along with partners the International Neuromodulation Society and Neuromodec.

"We're pleased to have such a distinguished lineup of speakers at the 2018 Neurotech Leaders Forum," said James Cavuoto, editor and publisher of Neurotech Reports. Neurotech Reports, founded in 2001, is the leading and longest-established publishing and market-research firm covering the neurotechnology industry.

For more information, contact James Cavuoto at 415-546-1259 or visit http://www.neurotechreports.com/pages/leadersforum.html.

Related link:

This news story was published by the Neotrope® News Network - all rights reserved.

Awards and Honors, Free News Articles, Surgery and Neurotechnology

Dr. Marchand Awarded World Record for Hysterectomy through the Smallest Incision Ever

MESA, Ariz. -- The World Record Academy today Awarded Dr. Greg J. Marchand, of Marchand Institute for Minimally Invasive Surgery, a world record for performing hysterectomy through the smallest incision ever. The surgery involved removal of a uterus, ovaries and Fallopian tubes all through an incision the diameter of an AAA battery. The record was awarded after a lengthy verification process performed by the academy to verify the results.

Dr. Marchand performed a hysterectomy through an 11mm incision at the bottom of the belly button using a technique called "laparoscopic single-port hysterectomy." Although laparoscopic hysterectomy has been performed through a single incision before, this is believed to be the smallest incision that it has ever been performed through. The Academy reported that the Mayo Clinic and Cleveland Clinic had reported cases through a 15mm incision, which was believed to be the previous record.

The patient, Mary Coble, provided the Academy with pictures of her belly from 4 weeks after the surgery. There was no scar visible whatsoever. Ms. Coble had suffered from debilitating pelvic pain from endometriosis and adenomyosis for years before being recommended to have the hysterectomy after other conservative treatments for her pain were unsuccessful. She assumed she would be having the hysterectomy through the same incision that she had her cesarean section went through, which was a lower abdomen horizontal incision, often referred to as the "bikini cut." She states she was surprised and delighted to find that the procedure was able to be performed through only a tiny incision in her umbilicus.

Dr. Greg Marchand, an Accredited Master Surgeon, developed this technique and led the surgical team that performed the surgery. The procedure was a modified version of a laparoscopic hysterectomy, where the only incision used is in the patient's umbilicus. "A very novel part of our technique," said Dr. Marchand, "is that because of the instrumentation we use, the incision is always going to be a reproducible 11 millimeters."

"The recovery was really easy compared to my prior laparoscopic surgeries," said Mary Coble following the procedure. Mary pointed out that she has no scars at all from the surgery, as the only tiny scar present is on the bottom of her belly button, where it is effectively invisible. Mary has previously had both laparoscopic surgery and delivered her baby by cesarean section, so she is no stranger to recovering from surgery.

"I think it's a great advancement for minimally invasive surgery." said Dr. Marchand, the lead surgeon. "When the incision shrinks from 15mm to 11mm, there are many benefits to the patient. There will be less postoperative pain, a quicker postoperative recovery, and a much lower chance of the incision causing a hernia later, which is a known complication of this type of surgery. My favorite part is that you can't even see the incision on the patient."

For media requests or more information, please contact Karen Thomas at Thomas PR at (631) 549-7575 or kthomas@thomaspr.com. Dr. Marchand is available for interview and Ms. Coble is also interested in sharing her story and interviewing for the purpose of raising awareness minimally invasive surgery and to help other women facing hysterectomy.

For more information regarding Dr. Greg Marchand, the Marchand Institute for Minimally Invasive Surgery, and their latest research publications, please visit: http://gregmarchandmd.com/.

For more information on the "Master Surgeon" Accreditation, please see the website of the Surgical Review Corporation at http://www.surgicalreview.org/.

--- Fact Sheet: ---

Date of Surgery: 07/17/2018

Date of Award of World Record Academy World Record: 08/22/2018

Actual Title of Record: "Total Hysterectomy Performed through the Smallest Incision"

Description of Technical Procedure Performed: Successful Single-port Total Laparoscopic Hysterectomy (LESS) with bilateral salpingo-oophorectomy and lysis of adhesions secondary to scar tissue from a prior cesarean section. The procedure was performed using an Olympus Tri-Port device using a modified technique through a smaller incision. The incision and abdominal entry was performed using an Ethicon 11mm blunt tip trochar in order to be sure the incision was exactly 11mm, and that the procedure was reproducible. A 5mm 30 degree laparoscope was used with wavy graspers, a bovie laparoscopic extender "hook," and a Covidien Ligasure Blunt Tipped 5mm device.

Method of Verification of Record: Direct video evidence of procedure and identifying information compared with final pathologic diagnosis by board certified pathologist. Patient consented to disclosure.

FAQ:

Can all hysterectomies be performed in this manner?

Our technique was successful in a difficult case that required dissection of scar tissue from a previous cesarean section, and also entailed scar tissue secondary to endometriosis. Unfortunately, some clinical scenarios involve worse pathology and may require a traditional laparoscopic or robotic assisted laparoscopic hysterectomy in order to be completed. We feel our technique is a valuable weapon in a surgeon's set of surgical skills but does not constitute a solution for every patient requiring a hysterectomy.

How Would Women Benefit if more Hysterectomies Were Performed Using this Technique?

With LaparoEndoscopic Single Site procedures (LESS), there is only a small scar in the area of the belly button. Because there are less incisions, the healing process is much faster and there is much less postoperative pain. In many cases patients can leave the hospital the same day as the surgery. The cosmesis is also considerably improved, with essentially no visible scars whatsoever. From a surgical perspective, you have a very complete visualization of the abdominal cavity at time of surgery, which is a big advantage for dealing with complex pathology such as endometriosis and fibroids. As a result complications are less common.

What is the invented technique?

The Marchand Institute for Minimally Invasive Surgery acknowledges prior published techniques for single port hysterectomy, also called LESS hysterectomy. There are also suggested techniques for various commercial available products developed for these surgeries. We theorized and performed a surgical technique that utilizes many of the advantages of traditional LESS surgery with an entry that utilizes a bench-marked 11mm blunt laparoscopic trochar port. The end result is a reproducible surgical technique that will continually produce a small incision in the umbilicus of exactly 11mm that is created with a blunt trochar and extremely cosmetic while also providing excellent exposure to the abdomen.

What is the Marchand Institute for Minimally Invasive Surgery, and what do they do?

The Marchand Institute for Minimally Invasive Surgery is a research and educational not-for-profit corporation and functional "Think-Tank" for the advancement of Minimally Invasive Surgery. We are located in Mesa, AZ. Our efforts are split between the publication of high-quality medical research, expert level surgical education, and involvement in clinical trials related to advancing Minimally Invasive Surgery.

Did this record involve "morcellation"?

No. Total Laparoscopic Hysterectomy generally does not require morcellation except in extreme cases, such as Dr. Marchand's 2008 Guinness World Record. For more details involving the 2008 World Record Please see: http://gregmarchandmd.com/guinness-record-marchand/

What do Dr. Marchand's accreditations mean ?

The accreditations represent honors bestowed upon Dr. Marchand by different certifying organizations. They include:

MD - Medical Doctor

FACOG - Fellow of the American College of Obstetrics and Gynecology - Certified by The American College/Congress of Obstetrics and Gynecology (acog.org)

FACS - Fellow of the American College of Surgeons - Certified by the American College of Surgeons (facs.org)

FICS - Fellow if the International College of Surgeons - Certified by The International College of Surgeons (fics.org)

Accredited Master Surgeon - Dr. Marchand is currently the only Accredited Master Surgeon in Arizona, - Certified by the Surgical Review Corporation (surgicalreview.org)

Why is this a world record? Can't a hysterectomy be done with no abdominal incision at all?

Yes, a hysterectomy can be performed vaginally without any abdominal incisions at all in uncomplicated cases without significant pathology. A completely vaginal approach, however, gives a very limited view of the abdomen and makes it difficult to deal with abdominal pathology such as scar tissue from prior surgeries and scar tissue from endometriosis. This can increase the chance of complications and injuries to surrounding organs. Using our technique we were able to directly visualize the abdominal cavity and perform the hysterectomy with less risk of complications. This was demonstrated by our ability to complete the hysterectomy safely despite this patient's history of prior cesarean sections and endometriosis. Our technique also has excellent cosmesis using only an 11mm incision that leaves essentially no scar.

How can you be sure that this is the smallest incision a laparoscopic Hysterectomy has ever been performed through? What steps did you take to verify?

We performed extensive searches of the literature in all of the relevant journals as well as PubMed. We were not able to find any reported case of total hysterectomy performed solely through this small of an incision. The World Record Academy then went on to verify the claim independently. We were awarded the record after the completion of their exhaustive verification efforts.

For media requests or more information, please contact Karen Thomas at Thomas PR at (631) 549-7575 or kthomas@thomaspr.com. Dr. Marchand is available for interview and Ms. Coble is also interested in sharing her story and interviewing for the purpose of raising awareness minimally invasive surgery and to help other women facing hysterectomy.

For more information regarding Dr. Greg Marchand, the Marchand Institute for Minimally Invasive Surgery, and their latest research publications, please visit http://gregmarchandmd.com/.

For more information on the "Master Surgeon" Accreditation, please see the website of the Surgical Review Corporation at http://www.surgicalreview.org/.

VIDEO (YouTube):
https://youtu.be/aNRxjVXECjc

Related link:

This news story was published by the Neotrope® News Network - all rights reserved.

Business, Free News Articles, Private Practice and Medical Groups, Surgery and Neurotechnology

Pinehurst Surgical Clinic Calls for Expansion of Affordable Medical Access in Richmond County Area

PINEHURST, N.C. -- Pinehurst Surgical Clinic (PSC) has served Richmond County and its surrounding areas since 1946 as a reliable and trustworthy provider of affordable surgical services. Offering a number of medical services, from a Urological Surgical Center and a Women's Care Center, Pinehurst Surgical Center has proved itself a valuable and necessary surgical resource in Richmond County.

"North Carolina is ranked as one of the lowest states in the nation when it comes to affordable healthcare. Pinehurst Surgical Clinic intends to be a catalyst of change by offering Richmond County a new approach to healthcare, we want to make it more accessible, affordable and trustworthy for this small community," said Robert J. Chamberlain, M.D, President of Pinehurst Surgical.

As an active member of the Richmond County community, PSC has witnessed a growing and increasingly urgent need for expanded medical access in the Richmond County Area. With the consolidation of two hospital providers in the area in recent years (FirstHealth Moore Regional-Richmond and Sandhills Regional Medical Center), residents have seen their options for surgical care greatly diminished.

More residents than ever are having to travel farther for simple outpatient surgical care. In 2015, 1,164 residents of Richmond County traveled out of the county to get a surgery. In 2018 however, 1,747 left the county for comparable procedures.

With a difference of 583 surgeries in a year, it's not only talking about convenience of care for the patients themselves but revenue for the county as well. Increased access to healthcare in Richmond County means PSC can bring jobs back to rural communities while lowering healthcare costs and increasing the quality of care overall, which are two of the main factors that American enterprises look for in their selection process when opening new facilities.

"Clinics like Pinehurst Surgical Clinic are the pillars of high quality low cost healthcare for the future, not just for rural communities but for any area looking to succeed," said David Grantham, M.D., Medical Director of Pinehurst Surgical.

Patients able to choose care through outpatient surgical clinic like PSC pay significantly lower out-of-pocket costs than patients who go through a hospital setting for their surgical care. It costs Medicare just 53 percent of the amount paid to hospital outpatient departments for the procedure as in a setting like PSC. That amounts to real-life savings for patients, as much as $400 for one procedure in some cases. These savings don't even take into the account the saved cost of travel. Traveling out of Richmond County for outpatient surgery often involves more than an hour-and-a-half roundtrip of driving or transit which can be a hardship for patients, particularly when multiple visits are required for pre- and post-op care.

The need for increased medical access in Richmond County is clear and urgent. By increasing their reach in Richmond County, Pinehurst Surgical Clinic can lower healthcare costs and improve quality of life in the community they've been proud to be a part of for over 70 years.

About Pinehurst Surgical:

Pinehurst Surgical, in Pinehurst, North Carolina, has been providing quality healthcare for more than 70 years. In addition to the main clinic in Pinehurst, the clinic also operates five satellite locations with First Health of the Carolinas and Scotland Healthcare, serving a six county primary care region. Forty-two physicians make Pinehurst Surgical, a multi-specialty group offering a range of services, including a Women's Care Center, general and bariatrics, vascular, orthopedic and joint replacement, ear, nose, throat, facial plastic, mohs surgery and urologic surgeries.

In partnership with Pinehurst Medical, Pinehurst Surgical provides access to over 100 physicians, forming one of the largest accountable care organizations in the surrounding six counties.

More information: http://www.pinehurstsurgical.com/.

Related link:

This news story was published by the Neotrope® News Network - all rights reserved.

Education and Schools, Free News Articles, Surgery and Neurotechnology

Magnifi Group and Bespa Global to Host Inaugural Annual Lower Extremity IEP Fellows and Young Surgeons’ Course

SAN DIEGO, Calif. -- Lower Extremity Fellows, Residents and Young Surgeons from leading U.S. Orthopaedic Centers and Hospitals will attend the 1st annual Lower Extremity IEP Fellows & Young Surgeons' Course, to be held in Austin, Texas, May 18-20, 2018, Magnifi Group announced today.

The three-day course has been specifically developed to educate attendees on current topics pertaining to the practice of foot and ankle surgery. The course will also assist with the transition into both academic and private practice. The course draws the industry's most prestigious faculty and is directed by Gregory C. Pomeroy, MD, Clinical Associate Professor of Surgery at the University of New England. Dr. Pomeroy also serves as the Director of the Division of Foot and Ankle Surgery, St. Mary's Regional Medical Center, Portland, Maine.

"This is the premier course in the U.S. that combines leading senior surgeons with young surgeons in practice, Fellows in foot and ankle, and senior residents who are planning to enter foot and ankle," Dr. Pomeroy said. "The course is designed for interaction between faculty and attendees," Pomeroy added.

Attendees will also participate in industry sessions presented by the course sponsors. Attendees will rotate through the exhibit hall in small groups, meeting and interacting with each course sponsor. Course Completion Certificates will be handed out upon conclusion of the course.

The course will be held at the Omni Austin Downtown and is exclusive to foot and ankle orthopaedic fellows, final year residents, and young surgeons within their first three years of practice.

For more information visit the 2018 Lower Extremity IEP Fellows and Young Surgeons' Course website at: http://lowerextremity-iep.com/.

About Magnifi Group:

Magnifi Group is a developer of dynamic online training solutions for leading global corporations. The company also hosts live courses for surgeons including the Spine IEP Fellows and Young Surgeons' Course and the Lower Extremity IEP Fellows and Young Surgeons' Course.

The company was founded in 2002 and has offices in San Diego, California and Wiesbaden, Germany. Learn more at: http://www.magnifigroup.com/.

About BESPA GLOBAL:

For over 12 years, BESPA USA, now known as BESPA GLOBAL has been dedicated to improving patient care through education and advancements in medical science. Their unique model is changing the way Medical Companies and Health Care Professionals work together to improve patient outcomes.

As an intermediary between Health Care Professionals and Medical Companies, BESPA GLOBAL delivers a variety of services including product development and education to medical companies and surgeons across Foot and Ankle, Plastic Surgery, Wound Healing and General Surgery. Learn more at: http://bespaglobal.com/.

Related link:

This news story was published by the Neotrope® News Network - all rights reserved.

Business, Free News Articles, Funding and Investment, Surgery and Neurotechnology

Neurotech Reports Announces 2018 Investment and Management Conference for Bioelectronic Medicine

NEW YORK, N.Y. -- Neurotech Reports, the publisher of Neurotech Business Report newsletter, today announced the launch of the Bioelectronic Medicine Forum, the first investment and management conference for the bioelectronic medicine industry. The inaugural event will take place on March 22, 2018 at the Millennium Broadway Times Square in New York, N.Y.

Featured speakers include Gene Civillico, Ph.D., the Program Manager for the National Institute of Health's SPARC program. Also presenting is Eric Van Gieson, Ph.D., Program Manager at DARPA's Biological Technologies Office, which oversees the ElectRx program. These two U.S. government programs have funded much of the early research into bioelectronic medicine.

Sessions will cover a range of technologies and indications for bioelectronic medicine, including applications in cardiovascular medicine, inflammation, gastrointestinal disorders, and many other clinical specialties. Attendees will hear from some of the leading researchers and entrepreneurs developing clinically and commercially promising products such as implanted vagus nerve stimulation systems to treat hypertension, and surface stimulation devices to treat a range of disorders.

Several early-stage and emerging bioelectronic medicine firms will be presenting at the conference. These include NeuSpera Medical, which is developing a unique mid-field power technology that uses the body as a waveguide to power bioelectronic devices. Also presenting is Axion Biosystems, a manufacturer of multi-well microelectronic electrode arrays, and Neuroelectrics, a Spanish firm that manufactures noninvasive stimulation and recording devices.

The conference is co-sponsored by the Feinstein Institute for Medical Research. Imran Eba of Action Potential Venture Capital, GSK's venture arm in bioelectronic medicine, will serve as a moderator. The event takes place in the same venue and one day prior to the Future Leaders Conference, which is produced and organized by BioCentury, a global leader in business intelligence for the biopharma industry. BioCentury is pleased to serve as a marketing partner of the Bioelectronic Medicine Forum.

"Bioelectronic medicine represents one of the fastest growing segments of the life sciences industry. Participants at the 2018 Bioelectronic Medicine Forum will have an opportunity to help shape the future of this exciting field," said James Cavuoto, editor and Publisher of Neurotech Business Report.

For more information, contact James Cavuoto at 415-546-1259 or visit http://www.neurotechreports.com/pages/bioelectronic-medicine-forum.html .

*PHOTO: Send2Press.com/300dpi/18-0130s2p-Gene-Civillico-300dpi.jpg

Related link:

This news story was published by the Neotrope® News Network - all rights reserved.

Business, Free News Articles, Product Launches, Surgery and Neurotechnology

TSI’s Phantom XL3 Lateral Access System Redefines the Standard of Care in Spine Surgery

SUGAR LAND, Texas -- TeDan Surgical Innovations (TSI) today announced the launch of the Phantom XL3(TM) Lateral Access System for lumbar spine surgical retraction. A full product release will be held later this month at the North American Spine Society Meeting (NASS) in Orlando from October 25 to 27.

Unencumbered access to the anatomy while maintaining a small surgical incision remains a clinical challenge for the minimally invasive surgeon. The all-new Phantom XL3 transforms the approach by eliminating instrumentation fiddle factor through the integration of unparalleled surgical access design elements - all with the focus of elevating the surgeon's experience.

"There are a variety of lateral lumbar retractors available today, but finding the system that meets all of your needs as a surgeon can be difficult. The intuitive design of the Phantom XL3 provides reliable retraction with a sweeping blade motion unlike any retractor on the market," said James J. Lynch, MD, FAANS, CEO Spine Nevada.

As a full solution to lateral lumbar access, the Phantom XL3 comes equipped with an integrated 360-degree directional EMG neuromonitoring dilator kit as well as lighting and shim components to provide additional stability and visualization.

"With a rise in minimally invasive approaches (MIS) for spinal fusions, we believe that the versatility and ease of use offered with our Phantom XL3 Lateral Access System will redefine the standard of care for MIS approaches," said Terry Johnston, VP of Sales and Marketing of TSI.

For a full product showcase, visit the TSI booth #1723 and attend the NASS Simulation Lab. To learn more about TSI's Phantom XL3 Lateral Access System or to register for the lab, visit http://www.tedansurgical.com/ or call 877-726-0886.

About TeDan Surgical Innovations:

TeDan Surgical Innovations was founded in 2006 with the goal to innovate and address evolving techniques in surgical access. The company has developed a wide variety of retractors and disc prep instruments for posterior, lateral and anterior spine, as well as cardiothoracic, neurological and orthopedic procedures. TeDan Surgical Innovations is committed to providing high-quality, state-of-the-art medical devices that address customer and market needs.

For more information about TeDan Surgical Innovations, please visit http://www.tedansurgical.com/.

*PHOTO for media: Send2Press.com/300dpi/17-1023s2p-tedanx3-300dpi.jpg
*Photo Caption: TSI's Phantom XL3 Lateral Access System

*VIDEO (YouTube): https://youtu.be/ymYlapWQHkQ

Related link:

This news story was published by the Neotrope® News Network - all rights reserved.

Books and Publishing, Entertainment, Free News Articles, Surgery and Neurotechnology

The 50th Anniversary of first Heart Transplant is Special Event to Veteran Transplant Surgeon Kristine Guleserian

MIAMI, Fla. -- December 3, 2017 marks the 50th anniversary of the world's first human-to-human heart transplant, notes Mark Oristano, author of "Surgeons' Story" (ISBN: 978-1935953784). South African physician Dr. Christiaan Barnard performed the surgery which astonished the world in Capetown. The patient, 54-year old Louis Washkansky, lived with another person's heart pumping his blood for 18 days.

Dr. Kristine Guleserian is a pediatric cardiothoracic surgeon at Nicklaus Children's Hospital in Miami. She says today the heart transplant is a common operation. In fact, as medical research improves, transplantation may become a thing of the past.

"We are seeing new techniques in human tissue engineering which may someday make it possible to repair parts of the heart which have been diseased," Dr. Guleserian says. "One thing I've learned in my years in cardiothoracic surgery is to never say 'never.'"

Dr. Guleserian also says there are mechanical advances which are helping patients with severe heart problems live longer before transplantation becomes necessary.

"Newer ventricular assist devices which help weak hearts pump more efficiently are enabling patients to survive longer as they wait for a donor heart to become available. The truth is that the supply has never kept up with the demand."

Dr. Guleserian's story is shared in the new book, "SURGEON'S STORY," by Mark Oristano. Her life, education, and career are laid out in detail. The surgeon who has performed more than 160 heart transplants will continue to perform the surgery as needed, while awaiting the next big cardiac breakthrough.

(To book Dr. Guleserian for interviews around the date of the transplant anniversary, use the contact information for Mark Oristano, found below.)

About Author Mark Oristano:
Mark Oristano is an author/journalist in Dallas, Texas. He spent a 30-year broadcasting career calling NFL football games for the Houston Oilers and Dallas Cowboys. He is a longtime volunteer at Children's Medical Center, Dallas, where he spent five years shadowing Dr. Kristine Guleserian for his new book, "Surgeon's Story."

SUMMARY - EDITIONS:
"Surgeon's Story" Kindle edition: B06XRDKMFS.
"Surgeon's Story" hardcover - ISBN: 978-1935953784.
"Surgeon's Story" paperback - ISBN: 978-1935953777.
Authors: Mark Oristano with Kristine Guleserian, MD.
Publisher: Authority Publishing.

MEDIA CONTACT:
For review copies, or to schedule interviews with the authors, contact:
Mark Oristano
214-546-3794
mark@oristano.net

IMAGES FOR MEDIA:
*PHOTO 1: Send2Press.com/300dpi/17-1016s2p-Guleserian-300dpi.jpg
*Caption 1: Dr. Kristine Guleserian (L) sews a new heart in to a two-year girl, one of over 160 transplants she has performed in her distinguished career.

*PHOTO 2: Send2Press.com/300dpi/17-0824s2p-surgstory-300dpi.jpg
*Caption 2: Book jacket, "Surgeon's Story" by Dr. Guleserian and Mark Oristano.

Related link:

This news story was published by the Neotrope® News Network - all rights reserved.

Awards and Honors, Free News Articles, Private Practice and Medical Groups, Surgery and Neurotechnology

Arizona Surgeon Invents and Performs World Record Setting Cancer Surgery

MESA, Ariz. -- The World Record Academy recently awarded Dr. Greg J. Marchand and his surgical team a world record for removing a 17-centimeter cancerous ovarian tumor using only small incisions in the abdomen, a technique called a laparoscopy. While removing cysts and tumors using laparoscopic surgery is a standard practice, Dr. Marchand said it is rare to use the technique in conjunction with an ovarian cancer staging procedure.

The surgeons completed the procedure using "in-bag" morcellation, a technique developed by Dr. Marchand in which the tumor is bagged and broken down inside the bag so the pieces can be safely removed through tiny holes. Otherwise, patients would need a sizeable incision to surgically remove such a large mass, requiring additional recovery time and a great deal more postoperative pain.

Marchand, a board-certified OB-GYN specializing in "minimally invasive surgery," worked closely with a gynecologic oncologist in completing this amazing surgery.

Marchand said the most difficult part of the surgery was removing the cancerous mass without spilling any cancer cells into the abdomen. If cancerous material spilled back into the abdomen the cancer could have spread and worsened the patient's prognosis.

The World Record Academy helped verify that this type technique had never been accomplished previously on any malignant tumor this large.

Dr. Marchand was diagnosed in 2010 with mixed-cell carcinoma, (an aggressive cancer of the testes,) said it is particularly gratifying that his technique can help cancer patients. He received surgery and treatments in 2010, and has been in remission since.

"I know what it's like to face a diagnosis of cancer," he said. "In my opinion, advancements in the surgical treatment of cancer are just as important as the newest cancer-fighting drugs and chemotherapy agents."

"If we can use minimally invasive surgery to take some of the recovery time and complications out of cancer surgery, then I think we've really done a lot of good for patients fighting cancer."

This is Dr. Marchand's second world record in laparoscopic surgery. In 2008 Dr. Marchand was awarded a Guinness World Record for the removal of the largest uterus laparoscopically. In this case, it was not a cancerous mass, but a seven-pound benign (non-cancerous) uterus that was removed.

In addition to the two world records, Dr. Marchand is extensively published in laparoscopic surgery and was recently the first U.S. surgeon to receive the "Master Surgeon" recognition from The American Association of Gynecologic Laparoscopist's (AAGL.org) and the Surgical Review Corporation (surgicalreview.org). Dr. Marchand is internationally regarded as an expert in developing and performing advanced surgical techniques, particularly in minimally invasive surgery. Dr. Marchand is currently the only "Master Surgeon" in the state of Arizona.

For further information regarding Dr. Marchand and his publications and research please visit http://gregmarchandmd.com/.

Fact Sheet:

Date of Surgery: 04/21/2015

Date of Award of World Record Academy World Record: 1/27/2017

Actual Title of Record: "Successful Laparoscopic Ovarian Cancer staging Surgery on the Largest Malignant Ovarian Tumor"

Method of Verification of Tumor Size: Pathology specimen reconstructed, verification by board certified pathologist.

Lead Surgeon: Greg J. Marchand M.D., F.A.C.O.G., F.A.C.S., F.I.C.S
Practice: Marchand OBGYN PLLC
1520 S. Dobson #308
Mesa, AZ 85202
p: 480-999-0905
f: 480-999-0801
www.gregmarchandmd.com

FAQ:
Why did it take so long for the World Record to be awarded?

To verify this record, we had to research all the other related surgeries that had been published to determine if ours was truly the largest malignant tumor ever surgically staged through completely laparoscopic means. After our research determined it was, we employed the World Record Academy who underwent their own verification process. Following the completion of these two independent verifications, we can now confidently say that this is likely the largest malignant ovarian tumor to ever undergo completely laparoscopic surgical staging.

What is "In-Bag" morcellation, how is it different from just breaking something apart, or regular morcellation?

In-Bag morcellation refers to the surgical technique of placing an object inside a bag, usually plastic, before breaking it into pieces. Usually the object is broken into small pieces so that it can be removed through small holes, thus not needing to make a large incision to remove the object. This high level of caution is reserved for objects that could contain cancerous cells. In the case of suspicion of cancerous cells, it is important not to spill the material back into the patient's body cavities because cancer cells can "Seed" or begin new cancer colonies if they are moved around the body. In this case, we removed a 17-centimeter cancerous tumor through a hole that was approximately 1.4cm large. This technique is one of the more extreme examples of "In-Bag" morcellation.

What does this mean to you as a cancer survivor?

"I underwent surgery and treatments after I was diagnosed with Mixed Cell Testicular Cancer in 2010. I am very lucky that the surgery for my stage of Testicular cancer was a very minimally invasive procedure, and that I had a good surgeon. I remember the horrible fear of 'just not knowing what was going to happen,' and I think that fear is really worse than any of the pain of the cancer or the treatments. When I woke up from the surgery, I really felt great, and over the next few days I had a very quick recovery.

"I was able to get back into my life quickly, and although I was still afraid of what was to come, I felt like I had the strength to fight. When I think about my patients with Ovarian cancer, I would like them to be able to come out of surgery feeling like they have the strength to fight, to take on the cancer. I can imagine that when you are recovering from a one of these big, open traditional staging procedures, you're in excruciating pain, you really can't move, and you like you've just been hit by a bus. I'm sure you don't feel strong and ready to fight the cancer at that point. You might just feel like giving up. If my technique can help even a few patients avoid that feeling, then thats the most valuable thing in the world to me.

"That's why I'm really passionate about what this new cutting edge technique can do for cancer patients, and I feel it can be just as valuable in the fight against cancer as the latest 'big pharma' wonder drug."

How can I find out more details?

Please contact the Marchand OBGYN PR department at the below address.
Maria Sainz - Marchand OBGYN Public Relations Manager
Marchand OBGYN PLLC
1520 S. Dobson #308
Mesa, AZ 85202
(480)999-0905
www.gregmarchandmd.com

VIDEO (YouTube): https://youtu.be/Kdy7bPiHWx0

Related link:

This news story was published by the Neotrope® News Network - all rights reserved.

Books and Publishing, Entertainment, Free News Articles, Surgery and Neurotechnology

In New Book, Renowned Pediatric Heart Surgeon Credits Her All-Girl School Education for Her Success

DALLAS, Texas -- As kids across the country get ready to go back to school, Dr. Kristine Guleserian, one of the nation's most accomplished pediatric heart surgeons, thinks back on her early school days very fondly. Guleserian is the co-author, with Mark Oristano, of "Surgeon's Story: Inside OR-1 with One of America's Top Pediatric Heart Surgeons" (ISBN: 978-1935953777).

Dr. G, as she's known to one and all, attended the Winsor School in Boston, and she credits the education she got there with starting her down the road to her current status as one of the country's top children's heart surgeons. In "Surgeon's Story," Dr. Guleserian described the teacher who opened up her world.

"One day the Greek teacher, Mrs. Dorothy Souvaine, wrote out the entire Greek alphabet and a few simple Greek words. The first word she wrote down was 'Bios,' meaning life. And then she wrote 'Logos,' meaning study of. 'Bioslogos.' So, biology - the study of life. I was fascinated. If I studied and became proficient in Greek, I could dissect out every word and understand its true meaning, I figured I'd have the fundamentals to understand anything."

"When I told my father that I was going to make Classics my concentration at Harvard he said, 'What are you gonna do with a degree in Greek? Go back and teach at the Winsor School?' When I went back to Boston for my 30th Winsor School reunion I found out they don't offer Greek anymore. They teach Chinese now."

Dr. G had another significant chance to visit Winsor in 2011, to lecture to the young girls sitting where she sat years before.

"I went back to the Winsor School in 2011 to give the annual Virginia Wing lecture. Miss Wing was the headmistress of the Winsor School when I was there. When I was a student at the Winsor School Dr. Tenley Albright, a gold medal Olympic figure skater who became a general surgeon, spoke to the student body in the very same assembly room I was in now. Dr. Albright's speech made a huge impression on me. I thought, 'Wow, a woman can be a surgeon!' And now I, a woman and a surgeon, was speaking to the student body. I can go to a surgical conference and they'll all listen to what I have to say. But in room full of students, I feel like everybody's listening, and the impact I can make there is huge."

Dr. Guleserian was the Surgical Director of Pediatric Cardiac Transplantation at Children's Medical Center in Dallas from 2007 to 2017. She is now on staff at Nicklaus Children's Hospital in Miami, where she is starting up a cardiac transplant program.

For more information on "Surgeon's Story: Inside OR-1 With One of America's Top Pediatric Heart Surgeons" visit http://surgeonsstory.com/.

About Author Mark Oristano:
Mark Oristano is an author/journalist in Dallas, Texas. He spent a 30-year broadcasting career calling NFL football games for the Houston Oilers and Dallas Cowboys. He is a longtime volunteer at Children's Medical Center, Dallas, where he spent five years shadowing Dr. Kristine Guleserian for his new book, "Surgeon's Story."

SUMMARY - EDITIONS:
"Surgeon's Story" Kindle edition: B06XRDKMFS.
"Surgeon's Story" hardcover - ISBN: 978-1935953784.
"Surgeon's Story" paperback - ISBN: 978-1935953777.

Authors: Mark Oristano with Kristine Guleserian, MD.
Publisher: Authority Publishing.


MEDIA CONTACT:
For review copies, or to schedule interviews with the authors, contact:
Mark Oristano
214-546-3794
mark@oristano.net

*PHOTO for Media: Send2Press.com/300dpi/17-0824s2p-surgstory-300dpi.jpg
*Photo Caption: Book jacket, "Surgeon's Story" by Dr. Guleserian and Mark Oristano.

Related link:

This news story was published by the Neotrope® News Network - all rights reserved.

Business, Free News Articles, Regional Events, Surgery and Neurotechnology

Key Startups and Industry Figures to Present at 2016 Neurotech Leaders Forum

SAN FRANCISCO, Calif. -- Several promising neurotechnology firms and key industry figures will present at the 2016 Neurotech Leaders Forum. The 16th annual event will take place October 24-25 in San Francisco, presented by Neurotech Reports. Keynote speaker at this year's event on October 24 will be Doug Weber, who serves as program manager for DARPA's Biological Technologies Office. Prior to joining DARPA, Weber was an associate professor of bioengineering at the University of Pittsburgh. He received his Ph.D. in bioengineering at Arizona State University.

On October 25, Adam Roth, Director of Business Development at Galvani Bioelectronics, will speak on the topic of bioelectronic medicine. Galvani was formed earlier this year as a joint venture between Google's Verily Life Sciences Unit and pharmaceutical giant GSK.

Other presenters at this year's conference are Jason Richey, president of LivaNova's neuromodulation unit, Jeff Kramer, vice president of research at St. Jude Medical Neuromodulation, David Hankin, CEO of the Alfred Mann Foundation, Frank McEachern, CEO of MicroTransponder, Inc., Aaron Kaluszka, research engineer at Lumos Labs, and Gaurav Sharma, principal research scientist at Battelle.

Neurotech entrepreneurs and startups presenting at the conference include Milton Morris, CEO of NeuSpera Medical, Roy Katz, vice-president at BlueWind Medical, Brian Blischak, president of Nexeon MedSystems, Howard Leonhardt, CEO of CerebraCell, and Chris Czura, CSO of Sanguistat.

The conference moves to a new location this year, the Embassy Suites San Francisco Airport-Waterfront in Burlingame, Calif.

Platinum Sponsor at this year's conference will be Micro Systems Technologies. Cirtec Medical is the Gold Sponsor. Stellar Technologies is the Silver Sponsor.

For more information on the Neurotech Leaders Forum, contact Neurotech Reports at 415-546-1259.

The preliminary agenda is online at: http://www.neurotechreports.com/pages/nlfagenda.html.

Overview of the 2016 Neurotech Leaders Forum: http://neurotechreports.com/pages/leadersforum.html.

*PHOTO for Media: Send2Press.com/mediaboom/16-1010s2p-ntleaders-300dpi.jpg

*Photo Caption: The Neurotech Leaders Forum returns to San Francisco October 24-25.

This news story was published by the Neotrope® News Network - all rights reserved.